Johnson & Johnson’s Vor Biopharma VOR Stock Holding History
Bought
Maintained
Sold
Other funds holding VOR
Johnson & Johnson's VOR Position: Q3 2026 in Review
Johnson & Johnson held its Vor Biopharma (VOR) position steady in Q3 2026 at 53,732 shares worth $1.03M. The position accounts for 0.13% of the portfolio, ranked #13.
Johnson & Johnson first reported a position in VOR in Q3 2021 and has held it in 21 quarters since. The position peaked at $16.9M in Q3 2021. 98 funds tracked by Wall St. Rank hold VOR as of Q3 2026.
- Johnson & Johnson held 53,732 shares of Vor Biopharma worth $1.03M as of Q3 2026.
- Johnson & Johnson left its Vor Biopharma share count unchanged in Q3 2026.
- Vor Biopharma made up 0.13% of Johnson & Johnson's portfolio in Q3 2026, its #13 holding.
- Johnson & Johnson first reported a position in Vor Biopharma in Q3 2021 and has held it in 21 quarters since.
- Johnson & Johnson's Vor Biopharma position peaked at $16.9M in Q3 2021.
- 98 funds tracked by Wall St. Rank held Vor Biopharma as of Q3 2026.
Based on Johnson & Johnson's 13F filing for Q3 2026, filed 26 Oct 2026.